Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 273,135 shares at $13.51 ($4.2M) on 2018-02-13, disclosed to the SEC on 2018-02-15.
Open-market sale of $4.2M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.51 | 55,078 | $744K | 17.7% |
| 2 | $13.51 | 55,078 | $744K | 17.7% |
| 3 | $16.69 | 162,979 | $2.7M | 64.6% |
| Total | $15.41 avg | 273,135 | $4.2M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |